Turkmenistan Medical Device Regulation: Legal Basis of Two Laws

1. Key takeaways

Medical device regulation in Turkmenistan has no standalone device law. The sources of regulatory authority are two laws:

• The Law of Turkmenistan on the Protection of Citizens’ Health (May 23, 2015) — the foundational law of the health sector, establishing the duty of the state to protect the health of citizens and the basic institutions of the healthcare field;
• Law No. 319-V of Turkmenistan on Drug Provision (January 12, 2016) — the backbone law for device registration and circulation, governing the purpose, scope, procedure and timelines of national registration, the validity of the registration certificate, and variations and renewal.

The most practical single sentence for companies entering this market: there is no medical device law to be found in Turkmenistan; the rules for devices are written into the drug law.

2. Legal basis

3. Expert insights

Insight 1: the two laws divide the work as a foundational law plus a specialized regime law, not a simple repetition of higher-ranking and lower-ranking rules.

The Law on the Protection of Citizens’ Health (May 23, 2015) establishes the foundational institutions of the health sector; Law No. 319-V on Drug Provision (January 12, 2016) then landed the concrete supply and registration regime early the following year. The two laws are about 8 months apart, which reflects a deliberate legislative sequence: first the foundational law, then the supply and registration regime built on top of it.

Insight 2: why devices are written into a drug provision law — this is path dependence of the post-Soviet regulatory system.

The regulatory system of Turkmenistan is inherited from the late-Soviet health administration structure, under which medical devices were long managed together with drugs as medical products. As a result, Law No. 319-V covers both medicines and medical devices, and the two categories share the same competent authority, the same registration procedure, and the same national registration register. Article 02 of this series unpacks the practical consequences of this structure item by item.

Insight 3: the regulation level is the operating manual, but it carries no public number.

Law No. 319-V provides that national registration is carried out by the authorized body in accordance with the Regulation on the State Registration of Medicines and Medical Devices approved by the Ministry of Health. In other words, the document that actually decides what you submit, how many copies, and in what language is this regulation — and it has no publicly available number or publication date. This is the largest single source of uncertainty in dossier preparation for this market, and it is the reason so many items in this guide are marked as practical estimates.

Insight 4: the A-grade evidence of this verification round is the ministry website itself.

We actually visited the website of the Ministry of Health and Medical Industry of Turkmenistan (https://www.saglykhm.gov.tm/), confirmed the formal name of the ministry (Turkmen: Türkmenistanyň Saglygy goraýyş we derman senagaty ministrligi) and its digital services section. The site also lists official links to the national e-services portal e.gov.tm, the digital portal sanly.tm, the Ministry of Justice minjust.gov.tm and the parliament mejlis.gov.tm — these four links are the basis on which we confirmed the official domain system.

Insight 5: the result of cross-checking the law name and number.

The name and date of Law No. 319-V (January 12, 2016) appear consistently in no fewer than four mutually independent sources, including sources using different English renderings such as On Drug Provision, On Medical Supplies and On Medicines Supply. The English titles differ, but the number and the date are identical — this is the basis on which we judge the law citable.

4. Practical recommendations

1. Do not create an entry for a Turkmenistan medical device law in your internal regulatory library; the correct entry is Law No. 319-V on Drug Provision and its implementing regulation.
2. Prepare the dossier on the assumption that drugs and devices share one regime, especially for procedure, timelines and variation rules; do not extrapolate from markets where devices are regulated independently.
3. Treat the current regulation and notices of the competent authority as the definitive document list, and obtain a written confirmation from the local representative before submission.
4. Always cite the law with its number and date — No. 319-V, January 12, 2016 — to avoid ambiguity from referring only to the drug law.
5. Maintain a whitelist of official domains: saglykhm.gov.tm, e.gov.tm, sanly.tm, minjust.gov.tm and mejlis.gov.tm; content outside these domains is not used as a regulatory source.

5. Verification checklist

• □ The internal regulatory library contains an entry for Law No. 319-V on Drug Provision (January 12, 2016).
• □ It is confirmed that Turkmenistan has no standalone device law and the dossier is prepared under the shared drug-and-device regime.
• □ The current document list has been confirmed in writing through the local representative.
• □ External citations of the law carry both the number and the date.
• □ A whitelist of official domains is in place and unofficial sources are excluded.

Regulatory information verified as of October 30, 2026. The content cited in this document was checked against the Law on the Protection of Citizens’ Health (May 23, 2015), Law No. 319-V on Drug Provision (January 12, 2016; the number and date confirmed across multiple independent sources) and the Regulation on the State Registration of Medicines and Medical Devices approved by the Ministry of Health; the ministry website (saglykhm.gov.tm) was verified by direct access.

GRZAN support in Turkmenistan: GRZAN provides registration support to manufacturers, importers and authorized representatives for this market. Local resources can be coordinated, including licensed importing entities and authorized representative arrangements, covering national registration submission, the consular legalization chain for documents, delivery of samples, alignment with mandatory TDS certification, and customs clearance support. Service capabilities include classification judgment, selection of the registration pathway, preparation of dossiers in the national format, notarization and consular legalization, preparation of testing and stability documentation, organization of GMP and ISO 13485 evidence, variations and renewal, and vigilance and post-market maintenance. Contact: info@grzanglobal.com.